. This strategy can and should be applied to other eating habits to improve diet quality, but effective implementation will require clear and practical policies set forth and monitored by the government, with the willing collaboration of food manufacturers. This is not an easy task; but it is worth pursuing because of the profound health benefits that the public stands to gain.
Strategies are also needed to combat food and nutrition misinformation and to effectively communicate evidence-based information to health professionals as well as the lay public. Clinicians face frustrating challenges in deciphering diet information and translating this into advice for their patients, which may discourage them from engaging in such conversations.
Even within government agencies, there has been a call for an increased effort to coordinate among the numerous diet-related initiatives to improve their impact
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Impact of the Human Cell Atlas on medicine - Nature MedicineIn their Perspective, Aviv Regev, Sarah Teichmann & colleagues discuss how cell atlases provide the missing links between genes, diseases and therapies — with benefits already seen in COVID-19, cancer and more teichlab sangerinstitute Cambridge_Uni teichlab sangerinstitute Cambridge_Uni How human cell atlases provide the missing links between genes, diseases and therapies HumanCellAtlas Genes Blood Cancer Diagnostic Genetic Genomic Medicine Therapeutics genentech sangerinstitute Cambridge_Uni
Source: NatureMedicine - 🏆 451. / 53 Read more »
Targeted therapy for osteoarthritis: progress and pitfalls - Nature MedicineNews and Views: Osteoarthritis is highly heterogeneous, so a 'one size fits all' approach to therapy is unlikely to succeed. Susanne Grässel & Nicole Schäfer discuss new trial data and the progress and pitfalls of targeted therapy for OA. uni_regensburg
Source: NatureMedicine - 🏆 451. / 53 Read more »
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy - Nature MedicineIn an analysis of adult patients with hematologic malignancies who received anti-CD19 chimeric antigen receptor T cell therapy, baseline gut microbiome composition was correlated with clinical response and treatment with broad-spectrum antibiotics in the four weeks prior to infusion was associated with worse survival and increased neurotoxicity.
Source: NatureMedicine - 🏆 451. / 53 Read more »
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial - Nature MedicineIn a prespecified interim analysis of a pivotal phase 2 trial, tisagenlecleucel, an autologous CD19-targeting CAR-T cell therapy, produced a high rate of complete responses with a manageable safety profile in adults with relapsed or refractory follicular lymphoma
Source: NatureMedicine - 🏆 451. / 53 Read more »
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial - Nature MedicinePresented at ASH21: In the phase 1 EXPLORER trial, avapritinib, a selective KIT inhibitor, was generally well tolerated and elicited durable clinical and molecular responses in patients with advanced systemic mastocytosis MPNsm ASH22
Source: NatureMedicine - 🏆 451. / 53 Read more »
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells - Nature MedicineA bedside-to-bench analysis identifies single-chain variable fragment linker length as an important component of chimeric antigen receptor (CAR) structure and suggests that, in contrast to CD28-based CAR T cells, tonic signaling can be beneficial for 4-1BB-based CAR T cell function.
Source: NatureMedicine - 🏆 451. / 53 Read more »